|
Volumn 2, Issue 6, 2001, Pages 428-431
|
The controversial association of the treatment of infertility with fertility agents and development of ovarian cancer: What should patients be told?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BUSERELIN;
CHORIONIC GONADOTROPIN;
CLOMIFENE CITRATE;
FERTILITY PROMOTING AGENT;
GONADORELIN AGONIST;
GOSERELIN;
HUMAN MENOPAUSAL GONADOTROPIN;
LEUPRORELIN;
AMENORRHEA;
ARTICLE;
CANCER INCIDENCE;
CANCER MORTALITY;
DIARRHEA;
DRUG MECHANISM;
FATIGUE;
FEMALE;
FEMALE INFERTILITY;
GYNECOMASTIA;
HEADACHE;
HOT FLUSH;
HUMAN;
INJECTION PAIN;
IRRITABILITY;
MULTIPLE PREGNANCY;
NAUSEA;
OVARY CANCER;
OVARY HYPERSTIMULATION;
RESTLESSNESS;
RISK FACTOR;
SIDE EFFECT;
THROMBOEMBOLISM;
UTERINE CERVIX MUCUS;
VERTIGO;
VISUAL DISORDER;
VOMITING;
|
EID: 0034885082
PISSN: 15328554
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (23)
|